CYTK - CYTOKINETICS INC
62.19
-0.080 -0.129%
Share volume: 1,509,690
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$62.27
-0.08
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-10-2024 | 08-09-2024 | 11-07-2024 | 02-27-2025 | 05-06-2025 | 08-07-2025 | 11-05-2025 | 02-26-2026 | |
| Assets | |||||||||
| Total Assets | 808.082 M | 1.524 B | 1.436 B | 1.402 B | 1.264 B | 1.226 B | 1.437 B | 1.425 B | |
| Current Assets | 638.704 M | 1.068 B | 1.019 B | 1.108 B | 956.053 M | 886.542 M | 977.349 M | 916.975 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 498.985 M | 866.633 M | 964.804 M | 981.157 M | 864.538 M | 783.195 M | 737.068 M | 759.703 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 119.976 M | 190.142 M | 46.888 M | 94.857 M | 73.680 M | 74.940 M | 225.467 M | 122.518 M | |
| Total Non-current Assets | 15.376 M | 305.361 M | 269.168 M | 145.055 M | 150.687 M | 178.201 M | 288.817 M | 335.048 M | |
| Property Plant Equipment | 68.018 M | 65.689 M | 64.222 M | 65.815 M | 67.175 M | 70.219 M | 76.001 M | 79.194 M | |
| Other Assets | 101.360 M | 390.289 M | 353.237 M | 227.918 M | 240.823 M | 268.874 M | 383.207 M | 428.368 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 808.082 M | 1.524 B | 1.436 B | 1.402 B | 1.264 B | 1.226 B | 1.437 B | 1.425 B | |
| Total liabilities | 1.204 B | 1.415 B | 1.450 B | 1.537 B | 1.530 B | 1.594 B | 1.958 B | 2.084 B | |
| Total current liabilities | 88.855 M | 102.777 M | 109.812 M | 179.674 M | 159.726 M | 131.064 M | 142.144 M | 202.452 M | |
| Accounts Payable | 12.967 M | 9.470 M | 11.581 M | 20.369 M | 13.942 M | 16.228 M | 22.084 M | 22.337 M | |
| Other liabilities | 508.775 M | 669.030 M | 695.661 M | 711.774 M | 725.570 M | 750.246 M | 767.265 M | 765.729 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 606.612 M | 643.431 M | 644.498 M | 645.597 M | 645.168 M | 713.045 M | 1.048 B | 1.116 B | |
| Other liabilities | 508.775 M | 669.030 M | 695.661 M | 711.774 M | 725.570 M | 750.246 M | 767.265 M | 765.729 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -396.160 M | 108.550 M | -13.911 M | -135.372 M | -266.413 M | -368.720 M | -521.123 M | -659.625 M | |
| Common stock | 1.852 B | 2.501 B | 2.532 B | 2.564 B | 2.595 B | 2.629 B | 2.783 B | 2.826 B | |
| Retained earnings | -2.248 B | -2.391 B | -2.552 B | -2.702 B | -2.863 B | -2.998 B | -3.304 B | -3.487 B |